
|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
- Volume 5
- Issue 8 Suppl
CME Quiz
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Introductionover 26 years ago
Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritisover 26 years ago
Methotrexate Therapy in the Year 2000: Outstanding Questionsover 26 years ago
State-of-the-Art Combination Therapy in 1999over 26 years ago
Selected Abstractsover 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
2
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
3
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
4
Experts Warn Binge Drinking Drives Early-Onset Breast Cancer, While Cessation Reduces Risk
5













































